Atypical Presentations of Thrombotic Thrombocytopenic Purpura: A Review

被引:32
作者
Sarode, Ravi [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
关键词
thrombotic thrombocytopenic purpura; rituximab; acute MI; stroke; VON-WILLEBRAND-FACTOR; HEMOLYTIC-UREMIC SYNDROME; FACTOR-CLEAVING PROTEASE; RETINAL VEIN OCCLUSION; CONCENTRATE BPL 8Y; MYOCARDIAL-INFARCTION; PATIENT; MUTATIONS;
D O I
10.1002/jca.20182
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thrombotic thrombocytopenic purpura (TTP) is diagnosed by the presence of microangiopathic hemolytic anemia and thrombocytopenia in a patient who frequently presents with central nervous system involvement and, to a lesser extent, renal dysfunction. Recent understanding of the pathophysiology of TTP due to severe deficiency of von Willebrand factor cleaving protease, known as ADAMTS13, has improved diagnosis of TTP. Once the diagnosis is suspected, life-saving therapeutic plasma exchange therapy is initiated. Occasionally, an unusual clinical presentation makes TTP diagnosis difficult, thus resulting in a delay in the management of TTP. This review highlights a variety of atypical TTP presentations described in the literature. It is intended to bring unusual scenarios to the clinician's awareness, so that timely treatment can be delivered. J. Clin. Apheresis 24:47-52. 2009. (c) 2008 Wiley-Liss, Inc.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 36 条
[21]  
Patel MR, 2001, ARCH OPHTHALMOL-CHIC, V119, P1388
[22]   Acute myocardial infarction in thrombotic microangiopathies -: clinical characteristics, risk factors and outcome [J].
Patschan, Daniel ;
Witzke, Oliver ;
Duehrsen, Ulrich ;
Erbel, Raimund ;
Philipp, Thomas ;
Herget-Rosenthal, Stefan .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (06) :1549-1554
[23]   Myocardial injury in thrombotic thrombocytopenic purpura: A frequent, perplexing complication [J].
Perez, Leandro ;
Ramappa, Preeti ;
Guzman, Jorge A. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 128 (02) :257-260
[24]   Post-appendectomy thrombotic thrombocytopenic purpura: A case report and review of the literature [J].
Robertson, Mandy D. ;
Zumberg, Marc .
AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (03) :224-228
[25]   COMPARISON OF PLASMA-EXCHANGE WITH PLASMA INFUSION IN THE TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA [J].
ROCK, GA ;
SHUMAK, KH ;
BUSKARD, NA ;
BLANCHETTE, VS ;
KELTON, JG ;
NAIR, RC ;
SPASOFF, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (06) :393-397
[26]  
Sarode R, 1997, AM J HEMATOL, V54, P102, DOI 10.1002/(SICI)1096-8652(199702)54:2<102::AID-AJH2>3.0.CO
[27]  
2-0
[28]  
Schwartz SG, 2000, ARCH OPHTHALMOL-CHIC, V118, P1304
[29]   Comparison and stability of ADAMTS13 activity in therapeutic plasma products [J].
Scott, Erik A. ;
Puca, Kathleen E. ;
Pietz, Bradley C. ;
DuChateau, Brian K. ;
Friedman, Kenneth D. .
TRANSFUSION, 2007, 47 (01) :120-125
[30]   The use of intermediate purity factor VIII concentrate BPL 8Y as prophylaxis and treatment in congenital thrombotic thrombocytopenic purpura [J].
Scully, Marie ;
Gattens, Michael ;
Khair, Kate ;
Liesner, Ri .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (01) :101-104